We cannot entirely exclude that superior tumor control in TEG011_CD8α may have been caused initially by more CD8 single-positive cells in the TEG011_CD8α product compared to TEG011 product, as CD4+/CD8+ ratios could not be entirely controlled in the experimental setup prior to infusion. Here, CD8A is linked to neoplasm.